2-Alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles: An Overview on Synthetic Strategies and Biological Activity.

about

2-Alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles: An Overview on Synthetic Strategies and Biological Activity.

Item

http://www.wikidata.org/entity/Q47397425

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

2-Alkylsulfanyl-4

@nl

2-Alkylsulfanyl-4(5)-aryl-5(4) ...... egies and Biological Activity.

@en

type

Item

label

2-Alkylsulfanyl-4

@nl

2-Alkylsulfanyl-4(5)-aryl-5(4) ...... egies and Biological Activity.

@en

prefLabel

2-Alkylsulfanyl-4

@nl

2-Alkylsulfanyl-4(5)-aryl-5(4) ...... egies and Biological Activity.

@en

P1476

2-Alkylsulfanyl-4(5)-aryl-5(4) ...... egies and Biological Activity.

@en

P2093

Francesco Ansideri

http://www.w3.org/2001/XMLSchema#string

P2860

Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase

Targeting the Gatekeeper MET146 of C-Jun N-Terminal Kinase 3 Induces a Bivalent Halogen/Chalcogen Bond

Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.

Pharmacophore design of p38α MAP kinase inhibitors with either 2,4,5-trisubstituted or 1,2,4,5-tetrasubstituted imidazole scaffold.

Comprehensive review in current developments of imidazole-based medicinal chemistry.

Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site.

Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a Dual p38α MAPK/PDE-4 Inhibitor with Activity against TNFα-Related Diseases.

Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis.

Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle.

3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.

P31

scholarly article

P356

10.1002/ARDP.201700258

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

350

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Koch

P577

2017-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29143361

http://www.w3.org/2001/XMLSchema#string